The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?

Journal of Bone and Mineral Research

Volumn 26, Issue 3, 2011, Pages 441-451

  Khosla, Sundeep ^a   Melton III, L Joseph ^a   Riggs, B Lawrence ^a  

^a MAYO CLINIC   (United States)

Author keywords

aging; menopause; Osteoporosis

Indexed keywords

ESTROGEN;

AGING; BONE CELL; CLIMACTERIUM; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL BONE; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; FRAGILITY FRACTURE; HUMAN; MOUSE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PATHOGENESIS; REVIEW; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; TRABECULAR BONE;

AGING; ANIMALS; BONE RESORPTION; DIAGNOSTIC IMAGING; ESTROGENS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MICE; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOPOROSIS; PERIMENOPAUSE;

EID: 79951839091     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.262     Document Type: Review

References (91)

1. Riggs BL, Melton LJ III., Evidence for two distinct syndromes of involutional osteoporosis. Am J Med. 1983; 75: 899-901.
2. Riggs BL, Khosla S, Melton LJ III., A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998; 13: 763-773. (Pubitemid 28224192)
3. Manolagas SC,. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010; 31: 266-300.
4. Riggs BL, Melton LJ III, Robb RA, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004; 19: 1945-1954. (Pubitemid 41103408)
5. Riggs BL, Melton LJI, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008; 23: 205-214. (Pubitemid 351160034)
6. Bonnick SL,. Skeletal anatomy in densitometry. In:, Bonnick SL, ed. Bone Densitometry in Clinical Practice. New York, NY: Humana Press; 1998: pp 35-78.
7. Rockoff SD, Sweet E, Bleustein J,. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res. 1969; 3: 163-175.
8. Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas P,. Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res. 2008; 23: 392-399. (Pubitemid 351304669)
9. Cooper C, Melton LJ,. Epidemiology of osteoporosis. Trends Endocrinol Metab. 1992; 3: 224-229.
10. van Staa TP, Dennison EM, Leufkens HG, Cooper C,. Epidemiology of fractures in England and Wales. Bone. 2001; 29: 517-522. (Pubitemid 33124293)
11. Riggs BL, Melton LJ,. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res. 2002; 17: 11-14. (Pubitemid 33150991)
12. Richelson LS, Wahner HW, Melton LJI, Riggs BL,. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med. 1984; 311: 1273-1275. (Pubitemid 15203470)
13. Syed FA, Modder UI, Roforth M, et al. Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J Bone Miner Res. 2010; 25: 2438-2446.
14. Nelson JF, Felicio LS, Randall PK, Simms C, Finch CE,. A longitudinal study of estrous cyclicity in C57BL/6J mice: I. cycle frequency, length and vaginal cytology. Biol Reprod. 1982; 27: 327-339. (Pubitemid 13230807)
15. Felicio LS, Nelson JF, Finch CE,. Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. cessation of cyclicity and the duration of persistent vaginal cornification. Biol Reprod. 1984; 31: 446-453. (Pubitemid 15208381)
16. Riggs BL, Khosla S, Melton LJ,. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002; 23: 279-302. (Pubitemid 34651948)
17. Nelson JF, Felicio LS, Osterburg HH, Finch CE,. Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol Reprod. 1981; 24: 784-794. (Pubitemid 11043205)
18. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML,. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res. 2007; 22: 1197-1207. (Pubitemid 351339702)
19. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston C,. Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens. J Clin Invest. 1997; 100: 1755-1759. (Pubitemid 27431332)
20. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL,. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab. 1998; 83: 2266-2274. (Pubitemid 28503012)
21. Greendale GA, Edelstein S, Barrett-Connor E,. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J Bone Miner Res. 1997; 12: 1833-1843. (Pubitemid 27500195)
22. Center JR, Nguyen TV, Sambrook PN, Eisman JA,. Hormonal and biochemica parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab. 1999; 84: 3626-3635. (Pubitemid 30645216)
23. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseau N, Chailurkit L,. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol. 1998; 49: 803-809. (Pubitemid 29009511)
24. van den Beld AW, de Jong FH, Grobbee DE, Pols HAP, Lamberts SWJ,. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab. 2000; 85: 3276-3282.
25. Amin S, Zhang Y, Sawin CT, et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med. 2000; 133: 951-963. (Pubitemid 32003511)
26. Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F,. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab. 2001; 86: 192-199. (Pubitemid 32109796)
27. Khosla S, Melton LJ, Atkinson EJ, O'Fallon WM,. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab. 2001; 86: 3555-3561. (Pubitemid 32755943)
28. Gennari L, Merlotti D, Martini G, et al. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab. 2003; 88: 5327-5333. (Pubitemid 37452735)
29. Van Pottelbergh I, Goemaere S, Kaufman JM,. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab. 2003; 88: 3075-3081. (Pubitemid 36877475)
30. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S,. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000; 106: 1553-1560. (Pubitemid 32038592)
31. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS,. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003; 88: 204-210. (Pubitemid 36115166)
32. Doran PM, Riggs BL, Atkinson EJ, Khosla S,. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men. J Bone Miner Res. 2001; 16: 2118-2125. (Pubitemid 32995404)
33. Uebelhart B, Herrmann F, Pavo I, Draper MW, Rizzoli R,. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels. J Bone Miner Res. 2004; 19: 1518-1524. (Pubitemid 41094354)
34. Amin S, Zhang Y, Felson DT, et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med. 2006; 119: 426-433.
35. Mellstrom D, Vandenput L, Mallmim H, et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res. 2008; 23: 1552-1560.
36. Khosla S, Melton LJ III, Robb RA, et al. Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. J Bone Miner Res. 2005; 20: 730-740. (Pubitemid 40571629)
37. Khosla S, Amin S, Orwoll E,. Osteoporosis in men. Endocr Rev. 2008; 29: 441-464. (Pubitemid 351831508)
38. Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 1992; 117: 1-9.
39. Bonewald LF,. Osteocyte messages from a bony tomb. Cell Metab. 2007; 5: 410-411. (Pubitemid 46825500)
40. Almeida M, Martin-Millan M, Plotkin LI, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007; 282: 27285-27297. (Pubitemid 47501960)
41. Tomkinson A, Reeve J, Shaw RW, Noble BS,. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab. 1997; 82: 3128-3135. (Pubitemid 27385687)
42. Mirza FS, Padhi ID, Raisz LG, Lorenzo JA,. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab. 2010; 95: 1991-1997.
43. Modder UIL, Clowes JA, Hoey K, et al. Regulation of circulating sclerostin levels by sex steroids in women and men. J Bone Miner Res. 2011; 26: 27-34.
44. Armstrong VJ, Muzylak M, Sunters A, et al. WNT/B-Catenin signaling is a component of osteoblastic bone cells' early responses to load-bearing, and requires estrogen receptor a. J Biol Chem. 2007; 282: 20715-20727. (Pubitemid 47100049)
45. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL,. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. 1999; 140: 4367-4370. (Pubitemid 30647136)
46. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL,. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest. 2003; 111: 1221-1230. (Pubitemid 36519939)
47. Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A. 2001; 98: 13960-13965. (Pubitemid 33116006)
48. Pfeilschifter J, Koditz R, Pfohl M, Schatz H,. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002; 23: 90-119. (Pubitemid 34185307)
49. Weitzmann MN, Pacifici R,. The role of T lymphocytes in bone metabolism. Immunol Rev. 2005; 208: 154-168. (Pubitemid 41746391)
50. Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R,. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest. 1999; 104: 503-513. (Pubitemid 29534334)
51. Shevde NK, Bendixen AC, Dienger KM, Pike JW,. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA. 2000; 97: 7829-7834. (Pubitemid 30460733)
52. Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of fas ligand in osteoclasts. Cell. 2007; 130: 811-823. (Pubitemid 47332572)
53. Martin-Millan M, Almeida M, Ambrogini E, et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. 2010; 24: 323-334.
54. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL,. Effect of blockade of TNF-a and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res. 2007; 22: 724-729. (Pubitemid 351339101)
55. Garnero P, Sornay-Rendu E, Chapuy M, Delmas PD,. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996; 11: 337-349. (Pubitemid 26076383)
56. Gregorio GB, Yamamoto M, Ali AA, et al. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17beta-estradiol. J Clin Invest. 2001; 107: 803-812. (Pubitemid 32274033)
57. Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology. 2002; 143: 2349-2356. (Pubitemid 34521581)
58. Dang ZC, Van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CWGM,. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res. 2002; 17: 394-405. (Pubitemid 34171754)
59. Bord S, Horner A, Beavan S, Compston J,. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab. 2001; 86: 2309-2314. (Pubitemid 32472956)
60. Sims NA, Dupont S, Krust A, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors beta in bone remodeling in females but not in males. Bone. 2002; 30: 18-25. (Pubitemid 34044296)
61. Hall JM, McDonnell DP,. The estrogen receptor beta-isoform (ER beta) of the human estrogen receptor modulates ER alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999; 140: 5566-5578. (Pubitemid 30645344)
62. Windahl SH, Hollberg K, Vidal O, Gustafsson JA, Ohlsson C, Andersson G,. Female estrogen receptor B-/- mice are partially protected against age-related trabecular bone loss. J Bone Miner Res. 2001; 16: 1388-1398. (Pubitemid 32677073)
63. Genant HK, Cann CE, Ettinger B, Gordan GS,. Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982; 97: 699-705. (Pubitemid 13251641)
64. Ritchie LD, Fung EB, Halloran BP, et al. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr. 1998; 67: 693-701. (Pubitemid 28153171)
65. Sowers MF, Corton G, Shapiro B, et al. Changes in bone density with lactation. JAMA. 1993; 269: 3130-3135. (Pubitemid 23171710)
66. Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R,. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res. 2000; 15: 129-137. (Pubitemid 30026940)
67. Budy AM,. Osteogenetic properties of estrogenic hormones. Ann NY Acad Sci. 1956; 64: 428-431.
68. Khosla S, Westendorf JJ, Oursler MJ,. Building bone to reverse osteoporosis and repair fractures. J Clin Invest. 2008; 118: 421-428. (Pubitemid 351206529)
69. Finkel T, Deng CX, Mostoslavsky R,. Recent progress in the biology and physiology of sirtuins. Nature. 2009; 460: 587-591.
70. Edwards JR, Zainabadi K, Elefteriou E, et al. The aging associated gene SIRT-1 regulates osteoclast formation and bone mass in vivo. J Bone Miner Res. 2007; 22 (Suppl): S29.
71. Edwards JR, Zainabadi K, Lwin ST, et al. The longevity genen SIRT-1 independently controls both osteoblast and osteoclast function. J Bone Miner Res. 2008; 23 (Suppl): S28.
72. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006; 444: 337-342. (Pubitemid 44764104)
73. Su JL, Yang CY, Zhao M, Kuo ML, Yen ML,. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem. 2007; 282: 19385-19398. (Pubitemid 47100112)
74. Grassi F, Tell G, Robbie-Ryan M, et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA. 2007; 104: 15087-15092. (Pubitemid 47619597)
75. Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med. 1998; 339: 733-738. (Pubitemid 28417356)
76. McKane RW, Khosla S, Risteli J, Robins SP, Muhs JM, Riggs BL,. Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. Proc Assoc Am Physicians. 1997; 109: 174-180. (Pubitemid 27164091)
77. Campisi J, d'Adda di Fagagna F,. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007; 8: 729-740. (Pubitemid 47312822)
78. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S,. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab. 1995; 80: 3304-3310.
79. Gennari C, Agnusdei D, Nardi P, Civitelli R,. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women. J Clin Endocrinol Metab. 1990; 71: 1288-1293.
80. McKane WR, Khosla S, Burritt MF, et al. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause-a clinical research center study. J Clin Endocrinol Metab. 1995; 80: 3458-3464.
81. Heshmati HM, Khosla S, Robins SP, O'Fallon WM, Melton LJ III, Riggs BL,. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res. 2002; 17: 172-178. (Pubitemid 33151009)
82. Khosla SK, Atkinson EJ, Melton LJ III, Riggs BL,. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab. 1997; 82: 1522-1527. (Pubitemid 27200429)
83. Wehr E, Pilz S, Boehm BO, Marz W, Obermayer-Pietsch B,. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol. 2010; 73: 243-248.
84. Prior JC,. Progesterone as a bone-trophic hormone. Endocr Rev. 1990; 11: 386-398. (Pubitemid 20182875)
85. Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2006; 91: 3697-3710. (Pubitemid 44536831)
86. Perrien DS, Achenbach SJ, Bledsoe SE, et al. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab. 2006; 91: 1848-1854.
87. Ebeling PR, Atley LM, Guthrie JR, et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 1996; 81: 3366-3371. (Pubitemid 26296217)
88. Sowers MFR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinal Metab. 2006; 91: 1261-1267.
89. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006; 125: 247-260.
90. Gao J, Tiwari-Pandey R, Samadfam R, et al. Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone (FSH). Endocrinology. 2007; 148: 2613-2621. (Pubitemid 46984812)
91. Drake MT, McCready L, Hoey KA, Atkinson EJ, Khosla S,. Effects of suppression of follicle stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab. 2010; 95: 5063-5068.